Status:
TERMINATED
Goal Directed Haemodynamic Treatment for Patients With Proximal Femoral Fracture
Lead Sponsor:
Karolinska Institutet
Conditions:
Femoral Fracture
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
The investigators aimed to compare the costs and consequences of 'routine perioperative fluid therapy' and 'GDHT in terms of morbidity, mortality, length of hospital stay, activity of daily living, he...
Detailed Description
The investigation is an open, randomized clinical study of individuals suffering from a proximal femoral fracture. The total study duration for each subject is approximately 12 months (+- 1 month); ea...
Eligibility Criteria
Inclusion
- Patients (men and women) age ≥ 70 years
- Patients´ scheduled for operation of proximal femoral fracture during office hours
- Patient who have a witnessed or written informed consent
Exclusion
- Any of the following is regarded as a criterion for exclusion from the study:
- Concomitant medication with Lithium
- Known allergy (or hypersensitivity) to Lithium, or components of the medical device
- Weight ≤ 40 kg
- Other conditions or symptoms preventing the subject from entering the study, according to investigators judgment
- Life expectancy less than 6 months and/or pathological fractures
- Not possible to insert arterial line.
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01141894
Start Date
March 1 2010
End Date
October 1 2014
Last Update
September 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Huddinge, Sweden, 14186